5KEG image
Entry Detail
PDB ID:
5KEG
Keywords:
Title:
Crystal structure of APOBEC3A in complex with a single-stranded DNA
Biological Source:
Host Organism:
PDB Version:
Deposition Date:
2016-06-09
Release Date:
2017-05-10
Method Details:
Experimental Method:
Resolution:
2.20 Å
R-Value Free:
0.22
R-Value Work:
0.17
Space Group:
I 2 2 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:DNA dC->dU-editing enzyme APOBEC-3A
Mutations:E72A, C171A
Chain IDs:A
Chain Length:203
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polydeoxyribonucleotide
Description:DNA (5'-D(*TP*TP*CP*TP*T)-3')
Chain IDs:B
Chain Length:15
Number of Molecules:1
Biological Source:synthetic construct
Primary Citation
Crystal structure of APOBEC3A bound to single-stranded DNA reveals structural basis for cytidine deamination and specificity.
Nat Commun 8 15024 15024 (2017)
PMID: 28452355 DOI: 10.1038/ncomms15024

Abstact

Nucleic acid editing enzymes are essential components of the immune system that lethally mutate viral pathogens and somatically mutate immunoglobulins, and contribute to the diversification and lethality of cancers. Among these enzymes are the seven human APOBEC3 deoxycytidine deaminases, each with unique target sequence specificity and subcellular localization. While the enzymology and biological consequences have been extensively studied, the mechanism by which APOBEC3s recognize and edit DNA remains elusive. Here we present the crystal structure of a complex of a cytidine deaminase with ssDNA bound in the active site at 2.2 Å. This structure not only visualizes the active site poised for catalysis of APOBEC3A, but pinpoints the residues that confer specificity towards CC/TC motifs. The APOBEC3A-ssDNA complex defines the 5'-3' directionality and subtle conformational changes that clench the ssDNA within the binding groove, revealing the architecture and mechanism of ssDNA recognition that is likely conserved among all polynucleotide deaminases, thereby opening the door for the design of mechanistic-based therapeutics.

Legend

Protein

Chemical

Disease

Primary Citation of related structures